Vertical: CNMBase Year: 2025
Market Size (2025)
$203.46M
Projected (2032)
$278.26M
CAGR (2022–2032)
4.6%
Key Players
9+
Market Overview
The Global Aquaculture Disinfectants Market was valued at USD 203.46 Million in 2025 and is projected to reach USD 278.26 Million by 2032, expanding at a CAGR of 4.57% over 2026–2032. The market has grown steadily from USD 177.86 Million in 2022, and the forecast period adds an absolute increment of USD 74.80 Million between 2025 and 2032. Growth is anchored in the structural expansion of farmed seafood production and in the steady replacement of antibiotic-based disease management with preventive biosecurity, in which disinfection of hatcheries, ponds, tanks, equipment, transport units and fish eggs is a routine and non-substitutable step.
Aquaculture is now the principal source of aquatic animal supply. The Food and Agriculture Organization of the United Nations (FAO) reported in The State of World Fisheries and Aquaculture 2024 that aquaculture produced 94.4 million tonnes of aquatic animals in 2022, representing 51% of the total and surpassing capture fisheries for the first time. As stocking densities rise and production intensifies, particularly in shrimp ponds and recirculating aquaculture systems (RAS), the exposure of farms to viral, bacterial and parasitic pathogens increases, and so does the frequency of disinfection cycles. Regulatory pressure to curb antimicrobial use in India, China, Chile, the European Union and North America further supports demand for registered disinfectants that leave low residues.
Key Findings
Product Type: Peroxygen & Others is both the largest and the fastest-growing product type, accounting for 40.0% of the market (USD 81.38 Million) in 2025 and growing at a CAGR of 5.66%. Iodine-based and Chlorine-based products each held 30.0% (USD 61.04 Million) in 2025.
Species: Shrimp and Fish each accounted for 45.0% of the market (USD 91.56 Million each) in 2025. Shrimp is the fastest-growing species segment at a CAGR of 5.25% and moves ahead of Fish from 2026 (USD 96.39 Million against USD 95.32 Million), reaching USD 131.06 Million by 2032.
Region: Asia Pacific is the leading region with 80.0% of global revenue (USD 162.77 Million) in 2025, while Middle East & Africa is the fastest-growing region at a CAGR of 6.06%.
Country: China is the leading country market at USD 84.64 Million in 2025, equal to 52.0% of Asia Pacific and 41.6% of the global market. Saudi Arabia is the fastest-growing country at a CAGR of 7.64%, while India, at 7.02%, is the fastest-growing large market.
Segmentation Summary
The market is segmented by product type into Iodine-based, Chlorine-based and Peroxygen & Others disinfectants, and by species into Shrimp, Fish and Others. Peroxygen & Others, which includes potassium peroxymonosulfate, hydrogen peroxide and peracetic acid formulations, is expected to grow from USD 81.38 Million in 2025 to USD 119.68 Million in 2032, contributing USD 38.30 Million of new revenue. Its rapid breakdown into oxygen-based by-products makes it the preferred chemistry for RAS and hatcheries. Iodine-based products (CAGR 4.04%) retain a firm position in fish-egg disinfection and in shrimp hatchery hygiene, while Chlorine-based products (CAGR 3.56%) remain the low-cost workhorse for pond preparation and water treatment, particularly in South and Southeast Asia and Latin America.
By species, Shrimp is projected to add USD 39.51 Million between 2025 and 2032, the largest increment of any species segment, reflecting the intensive, disease-prone nature of penaeid shrimp farming in China, India, Southeast Asia, Ecuador and other Latin American producers. Fish, which reaches USD 121.32 Million by 2032, is supported by salmonid, tilapia, carp and marine finfish production, where egg disinfection and equipment biosecurity are well-established. The Others segment, covering molluscs, crustaceans other than shrimp and ornamental species, grows at 3.49%.
Competitive Landscape Summary
The market is moderately fragmented. A small group of multinational chemical companies holds a strong position in branded peroxygen and peroxide chemistries, led by LANXESS (Virkon Aquatic), Evonik (VIGOROX Trident and ASPERIX), Solvay (PARAMOVE and AQUALISAN) and Ecolab (through CID LINES). Specialist aquaculture health companies such as Syndel in North America, Axcentive (Halamid, chloramine-T), Evans Vanodine (Buffodine iodophor) and Aquatiq (Aqua Des) compete on regulatory approvals, species-specific claims and technical service. In Asia, a large number of regional formulators, including Biostadt India, supply iodine, chlorine and other disinfectants to shrimp and fish farmers through agri-input distribution networks.
Challenges and Opportunities
Challenges: The market faces a fragmented and costly regulatory environment, in which a single active substance may need separate approvals as a biocide, a veterinary medicine or a pesticide depending on the jurisdiction and the label claim. Concerns over the toxicity of chlorine and its by-products to non-target aquatic life, price sensitivity among small-scale farmers in Asia and Africa, the presence of unregistered and low-quality products in informal markets, and limited awareness of correct dosing and contact times also restrain value growth.
Opportunities: The expansion of RAS and land-based salmon farming, the growth of shrimp farming in India, Ecuador and Southeast Asia, government restrictions on antibiotics in aquaculture, and the adoption of formal biosecurity programmes aligned with the World Organisation for Animal Health (WOAH) Aquatic Animal Health Code all create room for higher-value, registered disinfectants. Emerging aquaculture investment in Saudi Arabia, the UAE and other Middle Eastern markets offers fast-growing new demand.
Future Outlook
Over 2026–2032 the market is expected to grow at a 4.57% CAGR, with value shifting toward peroxygen chemistries and shrimp farming. Asia Pacific will remain the centre of demand, reaching USD 223.19 Million by 2032, while Latin America (CAGR 5.42%) and Middle East & Africa (CAGR 6.06%) outpace the global average. Suppliers with registered, pathogen-specific products and strong local distribution are best placed to benefit.
The Aquaculture Disinfectants Market market is projected to grow at a CAGR of 4.6% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Aquaculture disinfectants are chemical biocidal formulations used to inactivate or destroy pathogenic micro-organisms (viruses, bacteria, fungi, oomycetes and parasites) on surfaces, equipment, water and biological material in fish, shrimp and other aquatic animal farming operations. They are applied in hatcheries and nurseries, grow-out ponds, tanks, raceways, net pens, recirculating aquaculture systems (RAS), live-haul and well-boat transport, and processing-adjacent farm facilities. Typical uses include surface disinfection of fish eggs, pond bottom and water preparation between crop cycles, footbaths and wheel dips, disinfection of nets, tanks, pipes and tools, and treatment of intake water and effluent.
The active chemistries covered in this study fall into three groups. Iodine-based products are mainly iodophors such as povidone-iodine (PVP-iodine) and buffered iodine complexes, widely used for egg disinfection and hatchery hygiene. Chlorine-based products include calcium and sodium hypochlorite, trichloroisocyanuric acid (TCCA), sodium dichloroisocyanurate (SDIC), chlorine dioxide and chloramine-T, used for pond preparation, water treatment and equipment disinfection. Peroxygen & Others covers potassium peroxymonosulfate-based formulations, hydrogen peroxide, peracetic acid and other disinfectant classes such as quaternary ammonium compounds, glutaraldehyde and blended formulations.
Included: disinfectant products sold for aquaculture biosecurity and hygiene, whether registered as biocides, pesticides or veterinary products, valued at manufacturer and supplier level. Excluded: antibiotics and other antimicrobial drugs administered in feed, vaccines, probiotics and water-quality conditioners without a disinfection claim, feed additives, and disinfectants sold for seafood processing plants, livestock, poultry or human health uses.
Scope of the Study
The study quantifies the Global Aquaculture Disinfectants Market for the historic years 2022, 2023 and 2024, the base year 2025 and the forecast years 2026 to 2032. All values are expressed in USD Million and growth is expressed as the compound annual growth rate (CAGR) for 2026–2032.
Research Objectives
To estimate and forecast the size of the Global Aquaculture Disinfectants Market in value terms (USD Million) for 2022–2032.
To analyse the market by product type (Iodine-based, Chlorine-based, Peroxygen & Others) and identify the chemistries gaining share in hatchery, pond, RAS and equipment applications.
To analyse demand by species (Shrimp, Fish, Others) and relate it to production intensity and disease pressure in each farming system.
To assess the market across North America, Europe, Asia Pacific, Latin America and Middle East & Africa, and across the key producing countries in each region.
To identify the drivers, restraints, opportunities, trends and challenges shaping demand, including disease outbreaks and antimicrobial-reduction policies.
To examine the regulatory frameworks that govern the registration and use of aquaculture disinfectants in major markets.
To profile the competitive structure of the market and track product launches, approvals, partnerships and expansions since 2022.
To provide a value-chain, Porter's Five Forces and PESTEL assessment that supports strategic planning by manufacturers, distributors and investors.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. It begins with defining the market boundary, product taxonomy and segmentation, followed by an extensive review of secondary sources to build a baseline understanding of aquaculture production, disease incidence, disinfectant chemistries, regulatory status and competitive activity. Primary research with supply-side and demand-side participants is then used to validate assumptions, refine usage patterns and pricing, and test preliminary estimates. Market size is derived using both top-down and bottom-up approaches, reconciled through data triangulation, and projected over the forecast period using a factor-based forecasting model. Every estimate passes internal consistency checks to ensure that segment, regional and country values reconcile to the overall market total for each year.
Stage 1 – Market definition and scoping: product definitions, inclusions and exclusions, segmentation and geographic coverage.
Stage 2 – Secondary research: collection of production, trade, regulatory, company and pricing data.
Stage 3 – Primary research: interviews with industry participants to validate and refine findings.
Stage 4 – Market estimation: top-down and bottom-up sizing, followed by triangulation.
Stage 5 – Forecasting and validation: factor-based projection, sensitivity review and final quality checks.
Secondary Research
Secondary research drew on a wide range of public and proprietary sources relevant to aquaculture health and biosecurity:
Intergovernmental and government bodies: FAO fisheries and aquaculture statistics and The State of World Fisheries and Aquaculture reports; WOAH Aquatic Animal Health Code and disease notifications; NOAA Fisheries; the U.S. Food and Drug Administration Center for Veterinary Medicine (approved aquaculture drugs); the U.S. Environmental Protection Agency (antimicrobial pesticide registrations); the European Chemicals Agency (Biocidal Products Regulation); India's Department of Fisheries, Coastal Aquaculture Authority and MPEDA; China's Ministry of Agriculture and Rural Affairs; Norway's Medical Products Agency and Food Safety Authority; Chile's SERNAPESCA; and the UK Cefas Aquaculture Disinfectant Listing Scheme.
Industry associations: Global Seafood Alliance, World Aquaculture Society, Federation of European Aquaculture Producers, national shrimp and salmon farmers' associations and hatchery associations.
Company sources: annual reports, investor presentations, product labels, safety data sheets, registration dossiers and press releases of disinfectant manufacturers and distributors.
Trade and technical journals: aquaculture trade publications and peer-reviewed literature on disinfectant efficacy, pathogen inactivation and environmental fate.
Paid and statistical databases: trade statistics for disinfectant active ingredients, company financial databases and aquaculture production databases.
Primary Research
Primary research was conducted through in-depth telephone and online interviews with participants across the value chain. Supply-side respondents included product managers, regulatory affairs specialists and sales heads at disinfectant manufacturers, active-ingredient producers, formulators and aquaculture health distributors. Demand-side respondents included hatchery managers, farm owners and production managers of shrimp and finfish farms, aquatic animal health veterinarians, fish health biologists, and procurement teams at integrated seafood companies. Experts at research institutes and extension agencies provided additional perspectives on disease trends and biosecurity practice.
The objectives of primary research were to validate the market definition and segmentation; to understand application practices, dosing, frequency of use and product selection criteria by species and farming system; to gather insights on pricing, distribution margins and purchasing behaviour; to assess the impact of regulation and antimicrobial-reduction policies; and to verify the competitive positioning of leading suppliers.
Market Size Estimation
Top-down approach: The overall market was estimated from aggregate data on aquaculture production value and volume by region and species, combined with the share of farm operating costs spent on health and biosecurity products and the portion of that spend attributable to disinfectants. The global total was then split by region, country, product type and species using penetration ratios derived from secondary and primary research.
Bottom-up approach: Country-level demand was built from the number and capacity of hatcheries and grow-out farms by species, typical disinfection protocols (egg disinfection, pond preparation, equipment and footbath use, water treatment), application rates and frequencies, and average selling prices of each product type. Country totals were summed to regional and global totals, and cross-checked against the revenues of leading suppliers attributable to aquaculture disinfectants.
Data triangulation: The results of the two approaches were compared at the global, regional and segment level. Differences were reconciled by re-examining assumptions and consulting primary respondents, and the final estimates were adjusted so that the segment, regional and country values reconcile with the overall market total in every year.
Forecasting Methodology
The forecast was developed using a factor-based model that links disinfectant demand to the expected trajectory of aquaculture production and to changes in usage intensity and pricing. The factors considered include:
Projected aquaculture production growth by species and country, and the pace of intensification (stocking density, RAS adoption).
Frequency and severity of disease outbreaks and the resulting adoption of biosecurity protocols.
Antimicrobial-reduction regulations and their effect on preventive disinfection.
Regulatory approvals, product withdrawals and the cost of registration.
Shifts in chemistry preference, particularly toward peroxygen and low-residue products.
Raw-material cost trends for iodine, chlorine derivatives and peroxides, and their effect on prices.
Macroeconomic conditions, seafood trade flows and investment in new aquaculture capacity.
Each factor was weighted according to its expected impact over the short (2026–2027), medium (2028–2030) and long term (2031–2032). Year-on-year growth rates were applied to the 2025 base-year values, and the resulting forecasts were reviewed with industry participants before being finalised.
Assumptions and Limitations
Market values are expressed in nominal USD Million at manufacturer and supplier level; values in local currencies were converted at average annual exchange rates, and future exchange-rate movements are assumed to remain stable.
Aquaculture production is assumed to continue its long-term growth trend without a prolonged global disruption.
Current regulatory frameworks are assumed to remain broadly in place, with incremental tightening of antimicrobial and residue rules rather than abrupt bans on major disinfectant chemistries.
Major disease outbreaks are assumed to occur at frequencies consistent with recent history; an exceptional pandemic-scale outbreak could temporarily raise demand.
A portion of demand in Asia, Latin America and Africa is met through informal and unregistered channels for which data are limited; estimates for these channels rely on primary research and analyst judgement.
Some suppliers do not report aquaculture disinfectant revenue separately; company-level inputs therefore rely on estimates derived from product portfolios and interviews.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The aquaculture disinfectants market is moderately fragmented. At the global level, a limited number of multinational chemical and hygiene companies own the most widely recognised branded chemistries, particularly in the peroxygen, hydrogen peroxide and peracetic acid categories. Specialist aquaculture health companies hold important positions in regulated niches such as fish-egg disinfection and FDA-approved treatments, and a large number of regional and local formulators supply chlorine and iodine products to shrimp and fish farmers in Asia, Latin America and Africa.
Competition is shaped less by price alone than by regulatory approvals, label claims and access to farmers. In regulated markets such as the United States, Canada, the European Union, the United Kingdom and Norway, the cost of registration limits the number of approved products and gives incumbents a durable advantage. In emerging markets, distribution reach, technical field support and price are decisive. Leading suppliers increasingly differentiate through pathogen-specific efficacy data, compatibility with recirculating systems, sustainability attributes and integrated biosecurity programmes that combine products with protocols and training. Partnerships between manufacturers and specialist distributors are common, as illustrated by Syndel's distribution of Virkon Aquatic, Halamid Aqua and VIGOROX Trident in North America.
Key Player Positioning
Leaders: LANXESS and Syndel hold leading positions. LANXESS owns Virkon Aquatic, a potassium peroxymonosulfate disinfectant registered in multiple jurisdictions and positioned against key shrimp and fish pathogens, and produces the active ingredient in-house. Syndel combines its own FDA-approved and Health Canada-registered products, including Ovadine and 35% PEROX-AID, with the distribution of third-party disinfectants, giving it the broadest aquaculture-specific portfolio in North America.
Challengers: Evonik, Solvay and Ecolab bring large-scale chemical production and global reach. Evonik has moved from supplying commodity peroxides to offering registered aquaculture brands such as VIGOROX Trident and ASPERIX; Solvay supplies hydrogen peroxide-based PARAMOVE for salmon and AQUALISAN for shrimp ponds and works through joint ventures with aquaculture service companies; and Ecolab participates through its CID LINES animal health biosecurity business.
Niche players: Axcentive (Halamid, chloramine-T), Evans Vanodine (Buffodine iodophor egg disinfectant), Aquatiq (Aqua Des and treatment services in Norway and the United Kingdom) and Biostadt India (iodine and other disinfectants for Indian shrimp farmers) focus on specific chemistries, species or geographies where regulatory approvals, specialist expertise or local distribution give them a defensible position.
Competitor Dashboard
The competitor dashboard rates each company on four parameters relevant to the aquaculture disinfectants business: breadth of the aquaculture disinfectant product portfolio, regional presence, strategic alliances with distributors and partners, and industry experience in aquaculture health.
Threat of New Entrants – Medium
Registration requirements under biocide, pesticide and veterinary frameworks impose significant cost and time on new entrants, particularly in the EU, the United States and Norway.
In many Asian and African markets, entry barriers for generic chlorine and iodine products are low, and regional formulators can enter with limited capital.
Established suppliers benefit from brand recognition, pathogen-specific efficacy data and long-standing distributor relationships.
Bargaining Power of Suppliers – Medium
Iodine supply is concentrated among a small number of producing countries, which gives suppliers pricing power over iodophor formulators.
Chlorine derivatives and hydrogen peroxide are widely available commodities, limiting supplier leverage for those chemistries.
Several leading disinfectant brands are vertically integrated into active-ingredient production, reducing their exposure to supplier power.
Bargaining Power of Buyers – Medium
Large salmon and shrimp integrators purchase significant volumes and can negotiate prices and service terms.
Small farmers have little individual bargaining power but are highly price-sensitive and can switch to low-cost generics.
Where only a few products are approved for a specific use, such as fish-egg disinfection, buyer power is reduced.
Threat of Substitutes – Low
Physical methods such as ultraviolet irradiation, ozonation and filtration are used for water treatment in RAS and hatcheries, but they do not replace chemical disinfection of surfaces, equipment and eggs.
Probiotics, vaccines and genetic selection reduce disease risk but complement rather than substitute for disinfection.
Antibiotics are being restricted, which reduces rather than increases substitution risk.
Intensity of Competitive Rivalry – High
Numerous global, regional and local suppliers compete across overlapping chemistries and applications.
Price competition is strong in commodity chlorine and generic iodine products, particularly in Asia.
Branded suppliers compete on registrations, pathogen claims, technical service and distribution reach.
Threat of New Entrants: Medium; High registration barriers in regulated markets; low barriers for generics in emerging markets.
Bargaining Power of Suppliers: Medium; Concentrated iodine supply; commodity chlorine and peroxide inputs.
Bargaining Power of Buyers: Medium; Large integrators negotiate; small farmers price-sensitive; limited approved options for some uses.
Threat of Substitutes: Low; Physical treatments and preventive health tools complement rather than replace disinfection.
Competitive Rivalry: High; Fragmented supplier base with strong price competition in generic chemistries.
Market estimates by geography (2032)
InsightAsia Pacific leads with $223.19M by 2032, while Middle East & Africa is projected to grow fastest at a 6.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $9.11M | $10.95M | $13.13M | 3.7% | 5% |
| Europe | $12.82M | $15.26M | $18.11M | 3.5% | 7% |
| Asia Pacific | $142.13M | $178.15M | $223.19M | 4.6% | 80% |
| Latin America | $10.40M | $13.57M | $17.67M | 5.4% | 6% |
| Middle East & Africa | $3.40M | $4.58M | $6.15M | 6.1% | 2% |
| Total | $177.86M | $222.52M | $278.26M | 4.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$278.26M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Peroxygen & Others | $119.68M | 5.7% | 43% |
| Iodine-based | $80.56M | 4.1% | 29% |
| Chlorine-based | $78.02M | 3.6% | 28% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Aquaculture Disinfectants Market covering market dynamics, competitive landscape, and strategic outlook.
The Aquaculture Disinfectants Market market is projected to reach $278.26M by 2032, growing at 4.6% CAGR. The Peroxygen & Others segment holds the largest share.
Demand for aquaculture disinfectants is shaped by the interaction between production growth, disease pressure, regulation and farm economics. The Global Aquaculture Disinfectants Market grew from USD 177.86 Million in 2022 to USD 203.46 Million in 2025 and is forecast to grow at a CAGR of 4.57% over 2026–2032. This chapter sets out the macro and micro factors that influence the market, followed by a discussion of the principal drivers, restraints, opportunities, trends and challenges.
Market Growth Factor Analysis
The table below summarises five macro-level and five micro-level factors that influence the market. Each factor is classified by its impact type (promoting, inhibiting or steady) and assigned an impact score out of 10 for three periods of the forecast: 2026–2027, 2028–2030 and 2031–2032. The scores are analyst assessments based on secondary research and industry interviews, where 10 indicates the strongest influence on market growth in that period.
Expansion and Intensification of Global Aquaculture Production
Aquaculture has become the world's main source of aquatic animal food. According to FAO's The State of World Fisheries and Aquaculture 2024, aquaculture produced 94.4 million tonnes of aquatic animals in 2022, or 51% of total aquatic animal production, overtaking capture fisheries (92.3 million tonnes) for the first time. FAO's 2026 edition of the report indicates that aquaculture animal output exceeded 100 million tonnes in 2024. Production growth is increasingly achieved through intensification: higher stocking densities in shrimp ponds, larger salmon pens, multi-cycle hatcheries and closed recirculating systems. Intensive systems concentrate animals, feed and organic matter, which raises pathogen loads and the speed at which disease spreads. As a result, disinfection becomes a scheduled, recurring operating activity rather than an emergency response. Each additional hatchery, broodstock unit or grow-out cycle generates demand for egg disinfection, pond preparation, tank and equipment hygiene, footbaths and transport disinfection, so disinfectant consumption rises in line with, and often slightly ahead of, production volume.
High Economic Losses from Aquatic Animal Diseases
Infectious disease is the largest single cause of economic loss in aquaculture. The UK Centre for Environment, Fisheries and Aquaculture Science (Cefas) has estimated global aquaculture disease losses at more than USD 6 billion per year, and white spot syndrome virus (WSSV) alone has been estimated to cost the shrimp industry around USD 1 billion annually. Acute hepatopancreatic necrosis disease (AHPND), Enterocytozoon hepatopenaei (EHP), infectious salmon anaemia (ISA), salmonid rickettsial septicaemia (SRS) and tilapia lake virus continue to cause recurrent losses across Asia, Latin America and Europe. Because most viral diseases of shrimp and fish have no effective treatment, prevention through biosecurity is the primary control strategy. Disinfection of ponds between cycles, hatchery water and surfaces, broodstock and eggs, and equipment shared between sites breaks transmission routes. Suppliers increasingly support products with pathogen-specific efficacy claims, for example LANXESS markets Virkon Aquatic with efficacy data against EHP, reinforcing the link between disease pressure and disinfectant purchasing.
Regulatory Pressure to Reduce Antimicrobial Use
Governments in major producing countries are restricting antibiotic use in aquaculture, which shifts disease management toward prevention. In India, the Coastal Aquaculture Authority (Amendment) Act, 2023 explicitly includes disinfectants within the definition of aquaculture inputs and empowers the authority to prohibit harmful antimicrobial and pharmacologically active substances; the Coastal Aquaculture Authority Rules, 2024 and a February 2024 advisory require input manufacturers to obtain antibiotic-free compliance certification, and in 2025 the Ministry of Commerce and Industry prohibited a list of medically important antimicrobials in shrimp and fish culture and hatcheries. China has implemented a National Action Plan for Reducing the Use of Veterinary Antimicrobials (2021–2025) and has made aquaculture drug-use reduction part of its green aquaculture agenda. In Chile, SERNAPESCA monitors antibiotic use in salmon farming through its PROA-Salmon programme. These measures, together with residue testing by importing markets, push farmers toward disinfection and hygiene products that support antibiotic-free production.
Investment in Hatcheries, RAS and Formal Biosecurity Programmes
Capital investment in hatcheries, land-based recirculating aquaculture systems and specific-pathogen-free broodstock programmes is creating a structurally higher level of disinfectant use. RAS facilities require strict control of incoming water, eggs and equipment, as a single pathogen introduction can affect an entire closed system; they therefore favour peroxygen, hydrogen peroxide and peracetic acid products that decompose without persistent residues and are compatible with biofilters at controlled doses. Formal biosecurity frameworks are also spreading: the WOAH Aquatic Animal Health Code contains dedicated chapters on biosecurity for aquaculture establishments, disinfection of aquaculture establishments and equipment, and surface disinfection of salmonid eggs, while FAO published guidelines for its Progressive Management Pathway for Aquaculture Biosecurity in 2023. Certification schemes and retailer requirements likewise expect documented fish health and biosecurity plans, which translates into recorded, routine disinfection procedures.
Growth of Land-Based and Recirculating Aquaculture
Land-based salmon, trout, shrimp and marine finfish projects in North America, Europe, the Middle East and Asia are creating demand for high-specification disinfectants compatible with closed water systems. Products such as peracetic acid and hydrogen peroxide formulations, as well as peroxymonosulfate-based surface disinfectants, are well-suited to these systems. Suppliers that provide dosing guidance, biofilter-compatibility data and integrated hygiene protocols can secure long-term supply relationships with these capital-intensive facilities.
Formalisation of Input Markets in Major Shrimp-Producing Countries
India, the fastest-growing large country market with a CAGR of 7.02%, is formalising its aquaculture input market through Coastal Aquaculture Authority certification. Similar emphasis on traceability, antibiotic-free production and export-market compliance in Vietnam, Thailand, Indonesia and Ecuador favours registered and certified disinfectants over informal products. This creates an opportunity for established suppliers and local formulators with compliant portfolios to gain share from unregistered alternatives and to move farmers toward higher-value products.
Emerging Aquaculture Investment in the Middle East and Africa
Middle East & Africa is the fastest-growing region, with a CAGR of 6.06%. Saudi Arabia (CAGR 7.64%) and the UAE (CAGR 7.23%) are investing in shrimp, marine finfish and land-based aquaculture as part of national food-security strategies. New greenfield farms are typically designed with modern biosecurity standards from the outset, providing a receptive market for international suppliers of registered disinfectants, technical services and training.
Cost and Complexity of Product Registration
Aquaculture disinfectants are regulated under different frameworks depending on jurisdiction and claim, including the EU Biocidal Products Regulation (EU) No 528/2012, the US Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and US Food and Drug Administration approvals for aquaculture drugs, and national veterinary or input-certification rules in Asia. Generating efficacy, toxicology and environmental data for a relatively small market is expensive. In Europe, the cost of BPR authorisation has led many iodine-based fish-egg disinfectants to be withdrawn; Evans Vanodine has reported that authorising its Buffodine product cost more than EUR 100,000 and took around four years. High registration costs limit the number of approved products, discourage new entrants and slow the introduction of innovative chemistries.
Environmental and Handling Concerns
Several disinfectant chemistries are toxic to fish, shrimp and non-target aquatic organisms at application concentrations, and chlorine-based products can form halogenated by-products. Discharge of treated water and residues into surrounding waters is increasingly controlled by environmental permits, and improper dosing can harm stock or biofilters. Concentrated oxidising products also require careful storage and handling. These concerns restrict the application of certain chemistries directly in water, raise compliance costs for farmers and favour more expensive low-residue alternatives, which can slow volume growth in price-sensitive markets.
Price Sensitivity and Informal Product Channels
A large share of global aquaculture output comes from small and medium-scale farms in Asia, Latin America and Africa, where input purchasing is highly price-driven. Low-cost generic chlorine products, informally repackaged chemicals and unregistered products compete with branded, registered disinfectants. Limited access to technical advice also leads to under-dosing or inconsistent use, which reduces both efficacy and spend per farm. These factors cap value growth and make it difficult for premium suppliers to expand beyond large integrated producers and export-oriented farms.
Shift toward Peroxygen and Low-Residue Chemistries
Peroxygen & Others is the fastest-growing product type, with a CAGR of 5.66%. Farmers and regulators are favouring oxidising chemistries that break down into water, oxygen and simple salts. Evonik launched its EPA-registered VIGOROX Trident peracetic acid product for aquaculture in 2023, and in 2026 introduced a lower-carbon-footprint peracetic acid in Europe, illustrating the convergence of efficacy, low residue and sustainability claims.
Integration of Disinfection into Structured Biosecurity Programmes
Disinfection is increasingly sold as part of complete biosecurity programmes that cover farm zoning, footbaths, vehicle and equipment hygiene, water treatment and egg disinfection. Suppliers provide audits, protocols and staff training alongside products. Government listing schemes, such as the UK Aquaculture Disinfectant Listing Scheme operated by Cefas and Defra, give farmers a reference list of products tested against fish pathogens and reinforce structured purchasing.
Challenge: Ensuring Efficacy under Field Conditions
Organic matter, biofilms, water hardness, temperature and pH strongly influence disinfectant performance. Field conditions in earthen ponds and open systems often reduce efficacy compared with laboratory results, and incorrect dilution or insufficient contact time is common. Demonstrating consistent performance in real farm settings, and educating users on correct application, remains a central challenge for suppliers.
Challenge: Limited Approved Options for Minor Species and Uses
Because aquaculture is a relatively small and diverse market, few products are approved for each combination of species, life stage and use. In the United States, only a limited number of products are approved by the FDA for use in aquaculture, and in Europe, BPR costs have narrowed the range of authorised egg disinfectants. This limited choice creates supply concentration risk and can leave farmers without approved options for emerging diseases or new species.
The aquaculture disinfectants value chain links commodity chemical production with highly fragmented farm-level demand. Value is added mainly at the formulation and registration stage and through technical distribution, where product claims, approvals and on-farm advice differentiate suppliers.
North America
United States – EPA: Disinfectants with antimicrobial pesticide claims are registered under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) by the Antimicrobials Division of the EPA Office of Pesticide Programs. Virkon Aquatic (EPA Reg. No. 39967-137) and Evonik's VIGOROX Trident are examples of EPA-registered aquaculture products.
United States – FDA: Products used to treat or prevent disease in fish are regulated by the FDA Center for Veterinary Medicine. Approved aquaculture drugs include 35% PEROX-AID (hydrogen peroxide, NADA 141-255) and HALAMID AQUA (chloramine-T, NADA 141-423). Povidone-iodine used as a fish-egg surface disinfectant is listed by FDA as a low regulatory priority use under defined conditions.
Canada: Hard-surface disinfectants, including those for animal premises, are regulated as drugs under the Food and Drugs Act and require a Drug Identification Number (DIN) from Health Canada; products such as Virkon Aquatic, Ovadine and 35% PEROX-AID carry DINs. Certain treatments, such as hydrogen peroxide for sea lice control, are registered by the Pest Management Regulatory Agency under the Pest Control Products Act.
Europe
European Union – Biocidal Products Regulation (EU) No 528/2012: Disinfectants are authorised under product types including PT2 (disinfectants not intended for direct application to humans or animals), PT3 (veterinary hygiene), PT4 (food and feed areas) and PT5 (drinking water). The European Chemicals Agency administers active-substance approval and product authorisation.
European Union – Regulation (EU) 2019/6 on veterinary medicinal products: Products with therapeutic claims for fish are regulated as veterinary medicines rather than biocides.
United Kingdom: The Aquaculture Disinfectant Listing Scheme, operated by Cefas with Defra, lists products tested for efficacy against fish pathogens; UK biocide authorisation is required in parallel.
Norway: Regulation No. 821 of 2008 on the approval and use of disinfectants in aquaculture facilities and transport units requires approval of disinfectants used in aquaculture, administered by the Norwegian Medical Products Agency in cooperation with the Norwegian Food Safety Authority.
Asia Pacific
India: The Coastal Aquaculture Authority (Amendment) Act, 2023 includes disinfectants as aquaculture inputs and allows prohibition of harmful antimicrobial and pharmacologically active substances. The Coastal Aquaculture Authority Rules, 2024 require certification of inputs, and a 2024 advisory requires antibiotic-free compliance certificates for input products.
China: Veterinary drugs used in aquaculture are regulated by the Ministry of Agriculture and Rural Affairs. The National Action Plan for Reducing the Use of Veterinary Antimicrobials (2021–2025) and the 14th Five-Year Plan for fishery development promote reduced drug use and stricter residue control.
Japan: The Ministry of Agriculture, Forestry and Fisheries publishes the list of approved aquatic animal drugs and rules for their use.
Latin America and Middle East & Africa
Chile: SERNAPESCA oversees aquaculture health and monitors antimicrobial use in salmon farming through its PROA-Salmon programme.
International: The WOAH Aquatic Animal Health Code includes chapters on biosecurity for aquaculture establishments (Chapter 4.1), disinfection of aquaculture establishments and equipment (Chapter 4.4) and surface disinfection of salmonid eggs (Chapter 4.5), which serve as reference standards for national authorities in Latin America, the Middle East and Africa.
Aug 2022: Syndel / Axcentive; Product Launch; Syndel announced the availability of Halamid Aqua (chloramine-T) for U.S. aquaculture customers, following its FDA approval for specified bacterial diseases in freshwater-reared salmonids.
Oct 2022: LANXESS / Syndel; Regulatory Approval; Virkon Aquatic, LANXESS's potassium peroxymonosulfate disinfectant distributed by Syndel, was approved for use in California.
May 2023: Evonik; Product Launch; Evonik launched VIGOROX Trident, an EPA-registered peracetic acid product for water-quality control in recirculating systems, ponds and egg hatcheries.
Jun 2025: Solvay (Peróxidos do Brasil); Expansion; Peróxidos do Brasil, a Solvay joint venture, announced a USD 12 million investment to expand its hydrogen peroxide plant in Coronel, Chile, serving end markets that include aquaculture.
Mar 2026: LANXESS; Brand Milestone; LANXESS marked 40 years of the Virkon S brand, produced in Sudbury, United Kingdom, within its Biosecurity Solutions business, which also includes Virkon Aquatic.
Apr 2026: Aquatiq; Regulatory Listing; Aqua Des was added to the UK Aquaculture Disinfectant Listing Scheme operated by Cefas and Defra.
Jun 2026: Evonik; Product Launch; Evonik introduced a peracetic acid with a lower carbon footprint for the European market, available across its peracetic acid brands.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 31 companies operating in the Aquaculture Disinfectants Market market, including revenue, employee count, and market positioning where available.
Showing 31 of 31 companies
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
| Metric | FY2023 | FY2024 | FY2025 | FY2026 | |---|---|---|---|---| | Employees (approx., headcount) | 9000 | 9000 | 8700 | 8400 | Note: FY2023–FY2025 are approximations from company communications; the FY2025 figure is an interpolation and should be treated as not publicly verified. FY2026 (~8,400) is stated in every 2026 Solvay press release. The FY2025 media presentation references a workforce trajectory toward ~9,000 "by 2027" in a context that could not be fully parsed. Solvay is a 163-year-old Belgian producer of essential, largely commoditised inorganic and mid-chain chemicals whose franchise rests on scale, cost position and process know-how rather than proprietary molecules. Post-demerger, the group is anchored by two global leaderships — soda ash and its derivatives (including sodium bicarbonate) and hydrogen peroxide — complemented by highly dispersible silica for fuel-efficient tyres, the Brazil-based Coatis phenol/solvents chain, and a Special Chem unit housing rare earths and fluorine. With €4.3 billion of underlying sales and an EBITDA margin that has stayed above 20% through a severe soda ash downcycle, Solvay positions itself as a cash-generating, dividend-paying "essential chemistry" company. Its equity story now pivots on three levers: structural cost reduction (€300 million cumulative by end-2026), decarbonisation of coal-fired soda ash plants, and optionality in Western rare earths separation at La Rochelle — an asset increasingly seen as strategic outside China. --- ### Company's own description Solvay describes itself as "a pioneering chemical company with a legacy rooted in founder Ernest Solvay's pivotal innovations in the soda ash process," delivering essential solutions that address needs such as purifying air and water, preserving food, protecting health, making tyres more sustainable, and cleaning and protecting homes. Its corporate purpose, as presented with FY2025 results, is "essential chemistry, making progress possible for generations," executed through four strategic levers: operational excellence, energy transition, process innovation and production capacity (Source: FY2025 media presentation, 24 Feb 2026). ### Independent characterisation Solvay is today a mid-cap, cyclical, largely B2B commodity and intermediate chemicals producer. Roughly 60% of sales and around two-thirds of segment EBITDA come from Basic Chemicals (soda ash, bicarbonate, peroxides), where pricing is set by global supply-demand balances — notably the seaborne soda ash market, which has been depressed by Chinese and Turkish capacity additions. The remaining ~40% of sales (Performance Chemicals) are more differentiated (silica for tyres, rare earths formulations, autocatalyst materials, fluorine specialties, phenol/solvent chain) but smaller and more volatile in margin. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue mix | ~100% product sales; no material service, subscription or licensing revenue disclosed. Minor technology/licensing elements exist (e.g., samarium process technology supplied to Permag, 2025) but are not separately reported | | Contract structure | Soda ash: largely annual contracts in Europe/US, spot/short-term in seaborne Asia; peroxides: long-term on-site/captive supply to HPPO (propylene oxide) plants plus merchant sales; silica: multi-year qualifications with tyre makers | | Value chain position | Upstream/mid-stream: converts salt, limestone, trona, hydrogen, natural gas/energy and mineral concentrates into base inorganic chemicals and intermediates | | Cost drivers | Energy (gas, coal, power), CO2 allowances (EU ETS), freight, raw materials (limestone, salt, trona, ore concentrates), fixed costs | | Customer types | Glass manufacturers (flat, container, solar), detergent producers, chemical companies, tyre makers, pulp & paper, electronics/semiconductor fabs, food/feed/pharma, flue gas treatment operators, mining, automotive catalysts, magnet makers | | End-markets | Construction and automotive glass, solar glass, consumer goods (detergents), food & pharma (bicarbonate), environment (flue gas treatment, water), semiconductors (electronic-grade H2O2), mobility (tyres, catalysts, EV magnets), agro and coatings (solvents) | ### Segment business descriptions (as defined by Solvay) **Basic Chemicals:** Soda Ash & Derivatives and Peroxides businesses. **Performance Chemicals:** Coatis, Silica and Special Chem businesses (Source: Q1/Q2/FY2025 media presentations). **Corporate & Business Services:** corporate functions, energy services and other.
3 interactive charts drawn from the Aquaculture Disinfectants Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Aquaculture Disinfectants Market By Species
Global Aquaculture Disinfectants Market By Product Type
Global Aquaculture Disinfectants Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
